BioSpace News Archive

Aptorum Group Limited, a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announced President and Executive Director Darren Lui will share insight into the company’s recent developments and upcoming milestones during an investor webinar on Tuesday, May 19, 2020 at 4:00 p.m. ET.

As further evidence of the strong industry response to a potential new paradigm in the treatment of cancer, Varian (NYSE: VAR) today announced that Proton Therapy Pte., Ltd. ( http://www.proton.sg/ ) in Sin

Independent Data Monitoring Committee (DMC) to Review and Evaluate Patient Safety and Efficacy Data for Pivotal Phase 3 Trial of Galinpepimut-S in Patients with Acute Myeloid Leukemia in Second Remission Moshe Talpaz, M.D., Associate Director of Translational Research and Associate Chief of the Division of Hematology/Oncology at the University of Michigan Comprehensive Cancer Center to serve as DMC Chair Thomas Fleming, Ph.D., Professor and former biostatistics department chair of the

Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area. The ranking is compiled annually by the Washington Business Journal.

Harmonic Bionics, Inc. announced that they will be hosting live virtual demos of the company’s new upper body robotic rehabilitation system, Harmony SHR.

Pulmonx Corporation announced today that the French Health Ministry has granted national reimbursement for the Zephyr Endobronchial Valve, the first minimally-invasive treatment option for patients with severe emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD). The Zephyr Valve procedure, done through a simple bronchoscopy with no incision or cutting, is clinically proven to improve patients’ breathing

Seegene Inc., a leading developer of multiplex PCR technologies headquartered in South Korea, announced that it will export 10 million tests of its COVID-19 testing kits to Pan American Health Organization / World Health Organization through Brazilian subsidiary, Seegene do Brasil Diagnosticos Ltda.

Zebra-Med is the first AI startup securing FDA clearance for a population-health product helping health providers close the COVID-19-induced care gaps by identifying more patients at risk of osteoporosis, which costs $52B in the U.S. alone. Zebra-Med has also received its fourth U.S. patent in its bone health series, measuring potential risk for vertebral fractures KIBBUTZ SHEFAYIM, Israel--( BUSINESS WIRE )-- Zebra Medical Vision , the deep-learning

The Company’s Product Offerings Now Include 3 Additional Innovative Plant Based Gummies: CBD + Multi Vitamins, CBD + Fiber, and CBD + Biotin NEW YORK, NY, May 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today anno

The KIC Washington Center will continuously support the domestic biotech company’s entry into the U.S. market.